Michael H. Föhlings

… is Managing Director of TRON.


During his 30 years career in auditing, glass, steel and polymer industries, Michael has held diverse senior financial and general management functions in British, Anglo-Dutch and Swiss multinational companies. Concomitantly he was also a member of company boards in Germany, Italy, Spain, the United States and China.

He is a practitioner in the financial management of international multi-site groups operating in manufacturing business environments and gained practical experience in restructuring and repositioning companies in Germany, Spain and the US. He built up a number of financial and administrative organizations from the ground up before he joined TRON in 2011 as Managing Director, building up its financial and administrative structure. After Ugur´s step down as Scientific Director, Michael is TRON´s sole Managing Director.

Michael studied business administration, business and labour law and real estate management at Westfälische Wilhelms-University Münster, EBS European Business School, Schloss Reichartshausen and IMD, Lausanne, Switzerland. He holds Diplomas in Business Administration and Real Estate Management.



Ugur Sahin, M.D.

… is Co-Founder and Shareholder of TRON.


Ugur is a doctor of medicine, immunologist and cancer researcher.  His key focus is translating groundbreaking novel scientific ideas into medical innovations that help individual patients, an interest that was originally prompted by his experiences as a trained physician. His made key contributions in various fields of cancer immunotherapy, covering the discovery of tumor-associated antigens, development of novel monoclonal antibodies for the  treatment of solid cancers and various classes of RNA-based immunotherapies. Together with his team he has pioneered the concept of individualized cancer immunotherapies and in particular the development of mRNA-based vaccines that are tailored to each patient´s cancer mutation profile. Ugur is a Professor at the University Medical Center of Johannes Gutenberg University Mainz, co-founder and CEO of BioNTech and co-founder und shareholder of TRON.  He was TRON´s scientific managing director from 2010 until September 2019. Ugur supports the research and development at TRON as a close scientific advisor and supervisor for PhD students.